Identidad personal, neurotecnologías y Derechos Humanos
DOI:
https://doi.org/10.34117/bjdv9n1-228Keywords:
neurotecnología, dilema del control, neuroderechos, identidad personal, tetrahidrocannabinol, cerebro en una cubetaAbstract
El rápido desarrollo de las neurotecnologías y la inteligencia artificial en el siglo XXI plantea nuevos desafíos éticos y preguntas acerca de las posibles amenazas que representaría el uso incorrecto o malintencionado de estas técnicas. Surge así el dilema del control: ¿debemos regular la neurotecnología antes de que se consolide, arriesgándonos así a frenar su desarrollo, o debemos esperar a que se afiance para evaluar entonces su impacto ético, aun a riesgo de que pueda resultar demasiado tarde? En apoyo de una respuesta dirigida hacia la regulación temprana, el presente trabajo se centra específicamente en el posible impacto de la neurotecnología para el neuroderecho a la identidad personal. Basaremos nuestro análisis en dos ejemplos: un estudio de caso y una situación hipotética. El estudio de caso tratará sobre los efectos del compuesto activo de la marihuana, el tetrahidrocannabinol (THC). La situación hipotética consistirá en la posibilidad futura de que se cumpla el escenario conocido como “cerebro en una cubeta”.
References
ADAMCZYK, A. K. y ZAWADZKI, P. The memory-modifying potential of optogenetics and the need for neuroethics. En NanoEthics, 14, 2020, 207-225.
ANTONELLI, T., TOMASINI, M. C., TATTOLI, M., CASSANO, T., TANGANELLI, S., FINETTI, S., MAZZONI, E., TRABACE, L., STEARDO, L., CUOMO, V. y FERRARO, L. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. En Cerebral Cortex, 15, 12, 2005, 2013-2020.
BIECHELER, M. B., PEYTAVIN, J. F., SAM GROUP., FACY, F. y MARTINEAU, H. SAM survey on ‘drugs and fatal accidents’: Search of substances consumed and comparison between drivers involved under the influence of alcohol or cannabis. En Traffic Injury Prevention, 9, 1, 2008, 11-21.
CASPI A, MOFFITT, T. E, CANNON M, MCCLAY, J., MURRAY, R., HARRINGTON, H. L., TAYLOR, A., ARSENEAULT, L., WILLIAMS, B., BRAITHWAITE, A., POULTON, R. y CRAIG, I. W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. En Biological Psychiatry, 57, 10, 2005, 1117-1127.
CORTINA, A. y CONILL, J. Bioética y neuroética. En Arbor, 195, 792, 2019, a503.
DALING, J. R., DOODY, D. R., SUN, X., TRABERT, B. L., WEISS, N. S., CHEN, C., BIGGS, M. L., STARR, J. R., DEY, S. K. y SCHWARTZ, S. M. Association of marijuana use and the incidence of testicular germ cell tumors. En Cancer, 115, 6, 2009, 1215-1223.
DAVIS, N. J. y KONINGSBRUGGEN, M. V. “Non-invasive” brain stimulation is not non-invasive. En Frontiers in Systems Neuroscience, 7, 76, 2013, 1-4.
DI FORTI, M., IYEGBE, C., SALLIS, H., KOLLIAKOU, A., FALCONE, M. A.,PAPARELLI, A., SIRIANNI, M., LA CASCIA, C., STILO, S. A., REIS, T., HANDLEY, R., MONDELLI, V., DAZZAN, P., PARIANTE, C., DAVID, A. S., MORGAN, C., POWELL, J. y MURRAY, R. M. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. En Biological Psychiatry, 72, 10, 2012, 811-816.
DONALDSON, Z. R. y YOUNG, L. J. Oxytocin, vasopressin, and the neurogenetics of sociality. En Science, 322, 5903, 2008, 900-904.
ELVIK, R. Risk of road accident associated with the use of drugs: A systematic review and meta-analysis of evidence from epidemiological studies. En Accident Analysis and Prevention, 60, 2013, 254-267.
FRANKFURT, H. The importance of what we care about, Cambridge (Reino Unido), Cambridge University Press, 1988.
GALLI, J. A., SAWAYA, R. A. y FRIEDENBERG, F. K. Cannabinoid hyperemesis syndrome. En Current Drug Abuse Reviews, 4, 4, 2011, 241-249.
GENUS, A. y STIRLING, A. Collingridge and the dilemma of control: Towards responsible and accountable innovation. En Research Policy, 47, 1, 2018, 61-69.
GLEASON, K. A., BIRNBAUM, S. G., SHUKLA, A. y GHOSE, S. Susceptibility of the adolescent brain to cannabinoids: Long-term hippocampal effects and relevance to schizophrenia. En Translational Psychiatry, 2, 2012, e199.
GLENN, A. L. y RAINE, A. The neurobiology of psychopathy. En Psychiatric Clinics of North America, 31, 3, 2008, 463-475.
GOERING, S., KLEIN, E., SPECKER SULLIVAN, L., WEXLER, A., AGÜERA Y ARCAS, B., BI, G., CARMENA, J. M., FINS, J. J., FRIESEN, P., GALLANT, J., HUGGINS, J. E., KELLMEYER, P., MARBLESTONE, A., MITCHELL, C., PARENS, E., PHAM, M., RUBEL, A., SADATO, N., TEICHER, M., WASSERMAN, D., WHITTAKER, M., WOLPAW, J. y YUSTE, R. Recommendations for responsible development and application of neurotechnologies. En Neuroethics, 14, 2021, 365-386.
HALL, W. D. y LUCKE, J. C. The enhancement use of neuropharmaceuticals: More scepticism and caution needed. En Addiction, 105, 2010, 2041-2043.
HARMAN, G. Thought, Princeton (NJ), Princeton University Press, 1973.
HASIN, D. S., SAHA, T. D., KERRIDGE, B. T., GOLDSTEIN, R. B., CHOU, S. P., ZHANG, H., JUNG, J., PICKERING, R. P., RUAN, W. J., SMITH, S. M., HUANG, B. y GRANT, B. F. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. En JAMA Psychiatry, 72, 12, 2015, 1235-1242.
HICKEY, L. P. ‘The brain in a vat’ argument [en línea]. En Internet Encyclopedia of Philosophy. Disponible en: https://iep.utm.edu/brainvat/ [consultado el 6 de septiembre de 2022].
HYMAN, S. Ethical issues in pharmacology: Research and practice. En MARCUS, S. J. (ed.), Neuroethics: Mapping the field, San Francisco (CA), Dana Press, 2002, 135-143.
IENCA, M. y ANDORNO, R. Towards new human rights in the age of neuroscience and neurotechnology. En Life Sciences, Society and Policy, 13, 2017, 5.
IENCA, M. On neurorights. En Frontiers in Human Neuroscience, 15, 2021, 701258.
ILIEVA, I., BOLAND, J. y FARAH, M. J. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. En Neuropharmacology, 64, 2013, 496-505.
IPSER, J. y STEIN, D. J. Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents. En Psychopharmacology, 191, 1, 2007, 127-140.
IRONSIDE, M. L., JOHNSON, S. L. y CARVER, C. S. Identity in bipolar disorder: Self-worth and achievement. En Journal of Personality, 88, 1, 2020, 45-58.
KANAYAMA, G., HUDSON, J. I. y POPE., H. G. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? En Drug Alcohol Dependence, 98, 1-2, 2008, 1-12.
KNOCH, D., PASCUAL-LEONE, A., MEYER, K., TREYER, V. y FEHR, E. Diminishing reciprocal fairness by disrupting the right prefrontal cortex. En Science, 314, 5800, 2006, 829-832.
KUBANEK, J., BROWN, J., YE, P., PAULY, K. B., MOORE, T. y NEWSOME, W. Remote, brain region–specific control of choice behavior with ultrasonic waves. En Science Advances, 6, 21, 2020, eaaz4193.
LAGERBERG, T. V., KVITLAND, L. R., AMINOFF, S. R., AAS, M., RINGEN, P. A. ANDREASSEN, O. A. y MELLE, I. Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorder. En Psychiatry Research, 215, 1, 2014, 101-104.
LEITE, R. T., NOGUEIRA, S., DO NASCIMENTO, J. P., DE LIMA, L. S., DA NÓBREGA, T. B., DA SILVA, M., MONTE DA COSTA, L., BARBOSA, B. H. y GOMES DE MATOS, F. The use of cannabis as a predictor of early onset of bipolar disorder and suicide attempts. En Neural Plasticity, 2015, 434127.
LÓPEZ-MALO, D., SANCHEZ-MARTINEZ, J. J., ROMERO, F. J., BARCIA, J. M. y VILLAR, V. M. Oxidative stress and the combined use of tetrahydrocannabinol and alcohol: Is there a need for further research? En Reactive Oxygen Species, 2, 6, 2016, 388-395.
LÖSEL, F. y SCHMUCKER, M. The effectiveness of treatment for sexual offenders: A comprehensive meta-analysis. En Journal of Experimental Criminology, 1, 1, 2005, 117-146.
MAKIN, J. G., MOSES, D. A. y CHANG, E. F. Machine translation of cortical activity to text with an encoder–decoder framework. En Nature Neuroscience, 23, 2020, 575-582.
MARSHEL, J. H., KIM, Y. S., MACHADO, T. A., QUIRIN, S., BENSON, B., KADMON, J., RAJA, C., CHIBUKHCHYAN, A., RAMAKRISHNAN, C., INOUE, M., SHANE, J. C., MCKNIGHT, D. J., YOSHIZAWA, S., KATO, H. E., GANGULI, S. y DEISSEROTH, K. Cortical layer–specific critical dynamics triggering perception. En Science, 365, 6453, 2019, eaaw5202.
MEIER, M. H., CASPI, A., AMBLER, A., HARRINGTON, H. L., HOUTS, R., KEEFE, R. S. E., MCDONALD, K., WARD, A., POULTON, R. y MOFFITT, T. E. Persistent cannabis users show neuropsychological decline from childhood to midlife. En PNAS, 109, 40, 2012, E2657-E2664.
MUÑOZ, J. M. La optogenética: Fundamentos y retos ético-legales. En DEMETRIO, E. (dir.), Derecho penal y comportamiento humano, Valencia (España), Tirant lo Blanch, 2022, 747-758.
NEURORIGHTS FOUNDATION. The NeuroRights Foundation: New human rights for the age of neurotechnology [en línea]. Disponible en: https://neurorightsfoundation.org/ [consultado el 6 de septiembre de 2022].
PERLMUTTER, J. S. y MINK, J. W. Deep brain stimulation. En Annual Review of Neuroscience, 29, 1, 2005, 229-257.
POLO, L. La persona humana y su crecimiento, Pamplona, EUNSA, 1996.
POTOMAC INSTITUTE FOR POLICY STUDIES. Neurotechnology futures study [en línea], 2013. Disponible en: https://www.potomacinstitute.org/images/studies/NTFSReport-FINAL.pdf [consultado el 6 de septiembre de 2022].
PUTNAM, H. Reason, truth and history, Cambridge (Reino Unido), Cambridge University Press, 1981.
QAZI, R., GOMEZ, A. M., CASTRO, D. C., ZOU, Z., SIM, J. Y., XIONG, Y., ABDO, J., KIM, C. Y., ANDERSON, A., LOHNER, F., BYUN, S-H., LEE, B. C., JANG, K-I., XIAO, J. y BRUCHAS, M. R. Wireless optofluidic brain probes for chronic neuropharmacology and photostimulation. En Nature Biomedical Engineering, 3, 2019, 655-669.
REARDON, S. Pig brains kept alive outside body for hours after death. En Nature, 568, 2019, 283-284.
ROWLING, J. K. Harry Potter and the deathly hallows, Nueva York, Arthur A. Levine Books, 2007.
SAVULESCU, J. y PERSSON, I. Moral enhancement, freedom, and the God machine. En Monist, 95, 3, 2012, 399-421.
SECADES-VILLA, R., GARCIA-RODRÍGUEZ, O., JIN, C. J., WANG, S. y BLANCO, C. Probability and predictors of the cannabis gateway effect: A national study. En International Journal on Drug Policy, 26, 2, 2015, 135-142.
SPAEMANN, R. Personas: Acerca de la distinción entre “algo” y “alguien”, Pamplona, EUNSA, 2000.
THIBAUT, F., BARRA, F. D. L., GORDON, H., COSYNS, P. y BRADFORD, J.M. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias. En World Journal of Biological Psychiatry, 11, 4, 2010, 604-655.
TURGAY, A.. Psychopharmacological treatment of oppositional defiant disorder. En CNS Drugs, 23, 1, 2009, 1-17.
UNTERRAINER, M. y ODUNCU, F. S. The ethics of deep brain stimulation (DBS). En Medicine, Health Care and Philosophy, 18, 2015, 475-485.
VELLEMAN, J. D. ¿Cómo nos entendemos?, Madrid, Avarigani, 2017.
VILLAR, V. M. El neuroderecho a la identidad personal, Trabajo Fin de Grado en Filosofía, Valencia (España), Universidad Católica de Valencia, 2021.
VRSELJA, Z., DANIELE, S.G., SILBEREIS, J., TALPO, F., MOROZOV, Y. M., SOUSA, A. M. M., TANAKA, B. S., SKARICA, M., PLETIKOS, M., KAUR, N., ZHUANG, Z. W., LIU, Z., ALKAWADRI, R., SINUDAD, A. J., LATHAM, S. R., WAXMAN, S. G. y SESTAN , N. Restoration of brain circulation and cellular functions hours post-mortem. En Nature, 568, 2019, 336-343.
WAJNERMAN, A. Is mental privacy a component of personal identity? En Frontiers in Human Neuroscience, 15, 2021, 773441.
WATSON, G. Free agency. En Journal of Philosophy, 72, 1975, 205-220.
WEINBERGER, A. H., PLATT, J. y GOODWIN, R.D. Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States. En Drug Alcohol Dependence, 161, 2016, 363-367.
WILSON, B. The case for neuropreservation [en línea]. En Alcor Life Extension Foundation. Disponible en: https://www.alcor.org/library/case-for-neuropreservation/ [consultado el 6 de septiembre de 2022].
WINTERS, K. C. y LEE, C. Y. S. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. En Drug and Alcohol Dependence, 92, 1-3, 2008, 239-247.
YOUNG, L., CAMPRODON, J. A., HAUSER, M., PASCUAL-LEONE, A. y SAXE, R. Disruption of the right temporoparietal junction with transcranial magnetic stimulation reduces the role of beliefs in moral judgments. En PNAS, 107, 15, 2010, 6753-6758.
YUSTE, R., GENSER, J. y HERRMANN, S. It’s time for neuro-rights. En Horizons, 18, 2021, 154-164.
YUSTE, R., GOERING, S., AGÜERA Y ARCAS, B., BI, G., CARMENA, J. M., CARTER, A., FINS, J. J., FRIESEN, P., GALLANT, J., HUGGINS, J. E., ILLES, J., KELLMEYER, P., KLEIN, E., MARBLESTONE, A., MITCHELL, C., PARENS, E., PHAM, M., RUBEL, A., SADATO, N., SPECKER SULLIVAN, L., TEICHER, M., WASSERMAN, D., WEXLER, A., WHITTAKER, M. y WOLPAW, J. Four ethical priorities for neurotechnologies and AI. En Nature, 551, 7679, 2017, 159-163.
